Klebsiella pneumoniae Carbapenemase Variants Resistant to Ceftazidime-Avibactam: an Evolutionary Overview - Hobson, Claire Amaris; Pierrat, Gautier; Tenaillon, Olivier; Bonacorsi, Stéphane; Bercot, Béatrice; Jaouen, Ella; Jacquier, Hervé; Birgy, André (Antimicrobial agents and chemotherapy, 2022)
Keywords: Anti-Bacterial Agents - pharmacology; Anti-Bacterial Agents - therapeutic use; Antimicrobial Chemotherapy; Azabicyclo Compounds - pharmacology; Azabicyclo Compounds - therapeutic use; Bacterial Proteins - genetics; beta-Lactamase Inhibitors - pharmacology; beta-Lactamases - genetics; Carbapenems - pharmacology; Ceftazidime - pharmacology; Ceftazidime - therapeutic use; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections - drug therapy; Klebsiella Infections - microbiology; Klebsiella pneumoniae - drug effects; Life Sciences; Microbial Sensitivity Tests; Minireview; KPC-3; insertions; KPC-2; deletions; trade-off; ceftazidime-avibactam; omega loop; KPC beta-lactamase; epidemiology; ceftazidime-avibactam resistance; spectrum; stability; KPC